Dr. Peter Aidan Savage's lab at the University of Chicago focuses on understanding the interactions between regulatory T cells and B cells, particularly in the context of autoimmune diseases. The lab investigates how specific subtypes of regulatory T cells can regulate self-reactive B cells, which are implicated in the development of autoimmune conditions. By exploring these immunological relationships, the lab aims to unveil mechanisms that maintain immune tolerance and prevent autoimmunity.

Dr. Kenneth Bader's lab at the University of Chicago focuses on improving treatment strategies for chronic deep vein thrombosis (DVT), a common blood clotting condition. The lab combines advanced ultrasound technology with thrombolytic drugs to break down clots more effectively. Ultimately, they aim to develop personalized treatment protocols that enhance recovery and prevent future complications for patients suffering from chronic DVT.

Dr. Ralph Weichselbaum's lab at the University of Chicago focuses on innovative cancer therapies using genetically-engineered bacteria. They specifically study how Bifidobacteria can be used to enhance treatment for challenging cancers like pancreatic cancer by improving the immune response and working synergistically with traditional therapies like radiation. The lab is pioneering in engineering these bacteria to precisely deliver therapeutic agents to tumors, potentially changing how we treat hard-to-reach cancers.

Dr. John E. Downey's lab at the University of Chicago focuses on enhancing brain-computer interfaces to help individuals with paralysis use prosthetic arms more effectively in daily life. The team investigates how to improve the coordination of arm and hand movements and harness more brain activity for better decoding. By developing biomimetic decoders and testing them in realistic virtual scenarios, they aim to create more reliable and flexible assistive technologies for users.

Dr. Xiaochuan Pan's lab focuses on developing advanced imaging techniques to improve breast cancer treatment, specifically through intraoperative imaging during breast conserving surgery. The lab aims to enhance the identification of cancerous margins in lumpectomy specimens, thereby reducing the re-surgery rates for patients. Additionally, they work on creating a database of imaging and histopathological data for breast cancers that supports machine learning and deep learning applications in cancer research.

Dr. Timothy J Carroll's lab at the University of Chicago focuses on developing innovative treatments for acute ischemic strokes. The lab is investigating a novel synthetic blood substitute called Sanguinate, which aims to improve blood flow and oxygen delivery to the brain during a stroke. By enhancing collateral blood vessel growth and providing targeted oxygen release, the research seeks to minimize brain damage and improve patient outcomes during emergencies.

Dr. Aaron Dinner's lab at the University of Chicago focuses on understanding the molecular mechanisms behind protein function using advanced computational techniques. The research integrates molecular dynamics simulations and machine learning to explore how proteins operate at the atomic level, particularly in relation to processes such as voltage sensing in nerve cells and the mechanical response of proteins in the inner ear. By gaining insights into these fundamental biological processes, the lab aims to contribute to the development of new therapeutic strategies for conditions like epilepsy and hearing loss.

Jueqi Chen's research lab at the University of Chicago studies how certain bacterial toxins, called cholesterol-dependent cytolysins (CDCs), can activate the body's immune system by stimulating a protein complex known as the NLRP3 inflammasome. This process helps fight off bacterial infections but can also lead to harmful inflammation if not properly regulated. By exploring the mechanisms behind this interaction, the lab aims to identify new strategies for designing antimicrobial drugs and understanding how pathogens affect human health.

Dr. Emily Rogalski leads a research lab at the University of Chicago focused on understanding cognitive resilience in aging and improving communication for individuals with neurological conditions. Her work aims to identify factors that contribute to exceptional cognitive performance in older adults, particularly those who are 'SuperAgers.' Additionally, she develops interventions to enhance the quality of life for patients with primary progressive aphasia, exploring both clinical trials and community-based solutions.

Dr. Ruth Anne Eatock's lab at the University of Chicago studies how the inner ear processes head movements to maintain balance and stable vision. The research focuses on different types of hair cells in the vestibular system, examining how they send signals to the brain during motion. By understanding the mechanisms behind sensory signal integration and how different nerve fibers encode head motion, this lab contributes to our understanding of balance and spatial orientation.

Dr. Sally Horne-Badovinac's lab at the University of Chicago focuses on how groups of epithelial cells migrate together and assemble their surrounding environments during tissue development and repair. Using fruit flies as a model organism, the lab investigates the local interactions between cells that promote coordinated movement and how these movements help to form structures like the basement membrane, which supports organs. This research is important for understanding processes such as wound healing, organ development, and diseases related to tissue structure.

Dr. Daria Esterhazy's lab focuses on understanding how certain immune cells, known as innate lymphocytes, develop and function in the body. These cells play a crucial role in our immune responses, particularly in how we react to infections and other challenges. The research involves exploring the genetic regulation of these cells to better understand their roles in health and disease, which could lead to new treatments for autoimmune diseases and infections.

Dr. Scott A. Oakes' lab at the University of Chicago focuses on understanding how the exocrine pancreas, specifically the enzyme pancreatic elastase, impacts the health of insulin-producing beta cells and contributes to type 1 diabetes. The lab investigates the crosstalk between exocrine and endocrine cells in the pancreas, exploring how dysregulation can trigger inflammation and autoimmunity. Their research aims to develop new therapeutic strategies to protect beta cells and potentially prevent type 1 diabetes.

Dr. Jingyi Fei's lab at the University of Chicago focuses on understanding membraneless organelles (MLOs) in eukaryotic cells. These organelles, which consist of proteins and RNAs, play crucial roles in cellular processes and are linked to various diseases. The lab aims to develop new methods to study the organization and function of MLOs at high resolution, which could ultimately lead to better therapeutic strategies for related health conditions.

David Freedman's research lab at the University of Chicago focuses on understanding how the brain makes quick decisions based on visual information. Through the study of neuronal activity in specific brain areas, the lab investigates how we learn to categorize visual stimuli, which is crucial for navigating our daily lives. Their work has important implications for treating cognitive disorders that affect visual recognition and decision-making, such as Alzheimer's disease and attention deficit disorder.

Dr. Thomas F Gajewski's lab focuses on improving cancer immunotherapy treatments by investigating why some patients do not respond to anti-PD-1 therapies. By studying the immune environment of tumors and the genetics involved, the lab aims to discover new ways to enhance the effectiveness of these therapies. The research combines insights from clinical samples and mouse models to explore various avenues for boosting anti-tumor immune responses.

Dr. Benjamin Glick's research lab at the University of Chicago focuses on understanding how the Golgi apparatus, a vital organelle in cells, regulates the traffic of proteins. By studying both yeast cells and mammalian cells, the lab investigates how proteins are organized, sorted, and recycled within the secretory pathway. Through advanced imaging techniques and genetic tools, they aim to unravel the molecular mechanisms that govern these processes, which are crucial for proper cell function.

Dr. Tatyana Golovkina's lab at the University of Chicago investigates how certain retroviruses interact with the immune system and the microbiota to influence viral infections and cancer development. They focus on understanding the regulation of immune responses by a special molecule called H2-O and exploring how gut bacteria can promote or impede the progression of leukemia induced by viruses. Their research aims to uncover new mechanisms that could improve vaccinations and therapeutic strategies against viral infections and cancer.

Dr. Christopher Manuel Gomez's lab at the University of Chicago focuses on understanding calcium channel gene disorders, which often lead to severe neurological issues. Their research delves into how mutations in these genes can result in different neuronal outcomes by studying the dual role of calcium channel genes—both as channel proteins and newly discovered transcription factors. The lab aims to develop innovative therapies that target the underlying biological mechanisms of these disorders.

Dr. Tao Xie's lab at the University of Chicago focuses on understanding the relationship between gut bacteria and Parkinson's disease (PD). The research aims to explore how changes in gut microbiota might influence the onset and progression of PD symptoms. The team conducts both cross-sectional and longitudinal studies on diverse patient populations, emphasizing the underrepresented Black community. Through advanced techniques, the lab aims to identify potential biomarkers for diagnosis and novel interventions for treating Parkinson's disease.